http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102268161-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate | 2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102268161-B1 |
titleOfInvention | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias |
abstract | The present invention provides a novel use of landiolol hydrochloride for the sustained reduction of heart rate during the treatment period of landiolol hydrochloride in the treatment of a person suffering from tachycardia, tachyarrhythmias or elevated blood pressure, wherein landiolol hydrochloride is at least administered at a constant dose of at least 5 μg/kg/min, in particular at least 10 μg/kg/min for a period of 2 hours, wherein the patient's heart rate and/or blood pressure is compared to the heart rate and/or blood pressure prior to treatment decreases continuously over the period, and no overshoot effect occurs after the end of the dosing. |
priorityDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.